06/04/2026
🤯 CMS has officially launched the Medicare GLP-1 Bridge Program.
Beginning July 1, 2026, and currently scheduled through December 31, 2027, eligible Medicare beneficiaries will be able to access certain GLP-1 weight-loss medications for a fixed $50 monthly copay—even though Medicare has historically not covered medications prescribed solely for weight loss.
What makes this especially noteworthy is that traditional Medicare still does not broadly cover Medical Nutrition Therapy (MNT) for obesity. Dietitian services remain largely limited to beneficiaries with diabetes and chronic kidney disease.
So we now have a pathway for medication access without a corresponding pathway for nutrition care for many beneficiaries.
As obesity treatment continues to evolve, it raises an important question:
Should Medicare expand access to evidence-based nutrition counseling alongside pharmacotherapy to improve outcomes and support long-term success?
MNT HealthcarePolicy